Evidence map›Paper›PMID 25458128›Full record

ReviewRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2014

Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets.

Tomas Skripcak, Claus Belka, Walter Bosch, Carsten Brink, Thomas Brunner, Volker Budach, Daniel Büttner, Jürgen Debus, Andre Dekker, Cai Grau and 22 more

Abstract readReview
In one paragraph

Review in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Machine learning applications in radiation oncology.Physics and imaging in radiation oncology · 2021
    Review
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Tomas SkripcakGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany. Electronic address: t.skripcak@dkfz.de.
Claus BelkaGerman Cancer Consortium (DKTK) Munich and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Walter BoschDept. of Radiation Oncology, Washington University, St. Louis, MO, USA.
Carsten BrinkLaboratory of Radiation Physics, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Thomas BrunnerGerman Cancer Consortium (DKTK) Freiburg and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Volker BudachGerman Cancer Consortium (DKTK) Berlin, German Cancer Research Center (DKFZ) Heidelberg, Germany.
Daniel BüttnerGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Jürgen DebusGerman Cancer Consortium (DKTK) Heidelberg and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Andre DekkerDept. of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Cai GrauCIRRO Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Sarah GullifordJoint Department of Physics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
Coen HurkmansDept. of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands; EORTC-Radiation Oncology Group, Brussels, Belgium; EORTC-Global Clinical Trial QART Harmonisation Group, Brussels, Belgium.
Uwe JustDept. of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
Mechthild KrauseGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany; Dept. of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Germany.
Philippe LambinDept. of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Johannes A LangendijkUniversity Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Rolf LewensohnDepartment of Radiation Oncology, Centre Georges - François Leclerc, Dijon Cedex, France.
Armin LührGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany; OncoRay - National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
Philippe MaingonEORTC-Radiation Oncology Group, Brussels, Belgium; Department of Radiation Oncology, Centre Georges - François Leclerc, Dijon Cedex, France.
Michele MasucciEurocanPlatform and Karolinska Institutet Stockholm, Sweden.
Maximilian NiyaziGerman Cancer Consortium (DKTK) Munich and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Philip PoortmansDepartment of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Monique SimonGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Heinz SchmidbergerARO-Speaker, University Medical Center Mainz, Germany.
Emiliano SpeziDept. of Medical Physics, Velindre Cancer Centre, Cardiff, UK.
Martin StuschkeGerman Cancer Consortium (DKTK) Essen/Düsseldorf and German Cancer Research Center (DKFZ) Heidelberg, Germany.
Vincenzo ValentiniRadiation Oncology Department GEMELLI-ART, Universita Cattolica S. Cuore, Rome, Italy.
Marcel VerheijDepartment of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Gillian WhitfieldThe Christie NHS Foundation Trust and the University of Manchester, Manchester, UK.
Björn ZackrissonUmea University, Department of Radiation Sciences, Oncology, Umea, Sweden.
Daniel ZipsGerman Cancer Consortium (DKTK) Tübingen and German Cancer Research Center (DKFZ) Heidelberg, Germany; Radiation Oncology, Medical Faculty and University Hospital Tübingen, Eberhard Karls University Tübingen, Germany; Chair Clinical Committee, ESTRO.
Michael BaumannGerman Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany; Dept. of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Germany.

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
ADVANCED TECHNOLOGY QA CENTERU24CA081647 · NCI · WASHINGTON UNIVERSITY · PI MICHALSKI, JEFF M. · 1999 to 2013
$22.8M
Cancer Research UK 10588NCI NIH HHS U24 CA081647NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

Disconnected cancer research data management and lack of information exchange about planned and ongoing research are complicating the utilisation of internationally collected medical information for improving cancer patient care. Rapidly collecting/pooling data can accelerate translational research in radiation therapy and oncology. The exchange of study data is one of the fundamental principles behind data aggregation and data mining. The possibilities of reproducing the original study results, performing further analyses on existing research data to generate new hypotheses or developing computational models to support medical decisions (e.g. risk/benefit analysis of treatment options) represent just a fraction of the potential benefits of medical data-pooling. Distributed machine learning and knowledge exchange from federated databases can be considered as one beyond other attractive approaches for knowledge generation within "Big Data". Data interoperability between research institutions should be the major concern behind a wider collaboration. Information captured in electronic patient records (EPRs) and study case report forms (eCRFs), linked together with medical imaging and treatment planning data, are deemed to be fundamental elements for large multi-centre studies in the field of radiation therapy and oncology. To fully utilise the captured medical information, the study data have to be more than just an electronic version of a traditional (un-modifiable) paper CRF. Challenges that have to be addressed are data interoperability, utilisation of standards, data quality and privacy concerns, data ownership, rights to publish, data pooling architecture and storage. This paper discusses a framework for conceptual packages of ideas focused on a strategic development for international research data exchange in the field of radiation therapy and oncology.

Indexed as

Databases, FactualBiomedical ResearchData CollectionData MiningElectronic Health RecordsHumansInformation DisseminationInternational CooperationNeoplasmsResearch DesignData exchangeData poolingInteroperabilityLarge scale studiesPublic dataRadiotherapy

Identifiers

PMID25458128
PMCPMC4648243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.